Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.380 | 2.380 | 0.000 |
Stocks | 97.960 | 97.960 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 23.765 | 19.028 |
Price to Book | 6.701 | 3.147 |
Price to Sales | 5.069 | 2.247 |
Price to Cash Flow | 19.351 | 12.420 |
Dividend Yield | 1.101 | 1.922 |
5 Years Earnings Growth | 14.198 | 11.722 |
Name | Net % | Category Average |
---|---|---|
Technology | 43.090 | 20.640 |
Healthcare | 36.750 | 13.705 |
Communication Services | 18.660 | 8.900 |
Consumer Cyclical | 1.500 | 11.303 |
Number of long holdings: 29
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 8.51 | 456.73 | +2.19% | |
Alphabet A | US02079K3059 | 8.22 | 182.99 | +0.46% | |
Apple | US0378331005 | 8.16 | 216.73 | +2.90% | |
Meta Platforms | US30303M1027 | 5.87 | 504.60 | +0.08% | |
NVIDIA | US67066G1040 | 5.83 | 124.30 | +0.62% | |
J&J | US4781601046 | 5.18 | 146.42 | +0.18% | |
Roche Holding Participation | CH0012032048 | 4.47 | 250.30 | +0.32% | |
Novartis | CH0012005267 | 4.31 | 96.72 | +0.57% | |
Broadcom | US11135F1012 | 4.28 | 1,640.80 | +2.20% | |
UnitedHealth | US91324P1021 | 4.26 | 494.65 | -2.87% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CIBC Nasdaq Index | 3.28B | 13.04 | 14.55 | 19.58 | ||
CIBC Nasdaq Index Premium Class | 3.28B | 13.42 | 15.51 | 20.61 | ||
CIBC US Broad Market Index | 2.2B | 12.65 | 10.33 | 12.90 | ||
CIBC US Broad Market Index Premium | 2.2B | 12.98 | 11.16 | 13.78 | ||
CIBC Managed Growth Portfolio T8 | 37.41M | 6.99 | 3.92 | 6.12 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review